Loading insider details...
Latest Form 4 (Jun 23, 2026): Grant/Award of 29,500 OLMA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 29,500 | n/a |
| Dec 9, 2025 | Akero Therapeutics, Inc. (AKRO) | Disposition to Issuer | 93,000 | n/a |
| Oct 10, 2025 | Akero Therapeutics, Inc. (AKRO) | Exercise/Conversion | 26,000 | $598.5K |
| Jun 13, 2025 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 24,150 | n/a |
| Jun 5, 2025 | Akero Therapeutics, Inc. (AKRO) | Grant/Award | 9,398 | n/a |
| Mar 27, 2025 | Akero Therapeutics, Inc. (AKRO) | Purchase | 91,309 | $4.09M |
| Feb 8, 2025 | Akero Therapeutics, Inc. (AKRO) | Purchase | 200,000 | $9.60M |
| Dec 18, 2024 | Olema Pharmaceuticals, Inc. (OLMA) | Sale | 700,761 | $4.73M |
| Jun 18, 2024 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 23,000 | n/a |
| Jun 11, 2024 | Akero Therapeutics, Inc. (AKRO) | Grant/Award | 26,000 | n/a |